What is the dose in ml of ondansetron (generic name for the medication) syrup (4 mg/5ml formulation) for a 10-month-old, 10 kg baby?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ondansetron Dosing for a 10-Month-Old, 10 kg Infant

For a 10-month-old infant weighing 10 kg, administer 1.5 mg of ondansetron, which equals approximately 1.9 mL of the 4 mg/5 mL syrup formulation.

Weight-Based Calculation

  • The standard pediatric dose of ondansetron is 0.15 mg/kg per dose with a maximum single dose of 16 mg 1, 2
  • For a 10 kg infant: 0.15 mg/kg × 10 kg = 1.5 mg per dose 1

Volume Conversion for 4 mg/5 mL Syrup

  • The concentration is 4 mg per 5 mL, which equals 0.8 mg/mL 1
  • To deliver 1.5 mg: 1.5 mg ÷ 0.8 mg/mL = 1.875 mL (can round to 1.9 mL or 2 mL for practical administration) 2

Critical Age Restriction

  • Ondansetron should only be used in infants ≥6 months of age due to limited safety and efficacy data in younger infants 1, 2
  • At 10 months of age, this infant meets the minimum age requirement 1, 2

Route Selection Based on Clinical Context

  • For mild symptoms (1-2 episodes of vomiting, no lethargy): Consider oral administration of 1.5 mg (approximately 2 mL of syrup) 2
  • For moderate symptoms (>3 episodes with mild lethargy): Administer 0.15 mg/kg intramuscularly if oral route is not feasible 2
  • For severe symptoms (>3 episodes with severe lethargy, hypotonia, or cyanosis): Administer 0.15 mg/kg intravenously if IV access is established 2

Safety Considerations

  • QT interval prolongation: Ondansetron can prolong the QT interval in a dose-dependent manner 1, 2
  • Avoid use in infants with congenital long QT syndrome, electrolyte abnormalities, or known cardiac conduction abnormalities without cardiology consultation 1, 2
  • Special caution is warranted in children with congenital heart disease 2

Common Pitfalls to Avoid

  • Do not exceed 16 mg as a single dose, regardless of weight-based calculation 2
  • Do not use in infants <6 months old, as this is outside the approved age range 1, 2
  • The dose can be rounded by up to 15% for practical home administration, so rounding 1.875 mL to 2 mL is acceptable 2

Monitoring

  • Monitor the infant for 4-6 hours from onset of symptoms to assess response 1
  • Observe for resolution of vomiting and improvement in clinical status 1

References

Guideline

Ondansetron Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ondansetron Dosing Guidelines for Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended dosage of ondansetron (generic name for Zofran) for a child?
What is the recommended dosage of ondansetron (Zofran) for a 15-year-old and a 13-year-old?
What is the recommended dose of ondansetron (Zofran) for pediatric patients?
What is the appropriate dose of ondansetron (antiemetic medication) for a pediatric patient weighing 19.5kg?
Should a 31-year-old female with a history of Nexplanon (etonogestrel implant) complications, presenting with left upper arm pain radiating to the wrist and thumb, and right arm burning pain at the antecubital (A/C) site, be evaluated in person or can she receive a refill for Ondansetron HCl (ondansetron hydrochloride) over the phone?
What is the role of autonomic testing, such as tilt table test and heart rate variability (HRV) testing, in diagnosing and managing a patient suspected of having Postural Orthostatic Tachycardia Syndrome (POTS)?
What is the best management for a post-COVID-19 patient with shortness of breath on exertion, clear chest x-ray, and clear chest computed tomography (CT) scan, considering options such as a nebulizer or metered-dose inhaler (MDI) with medications like albuterol?
For a 5-year-old male child with a penis swab positive for Morganella morganii, is topical treatment sufficient?
What is the best treatment for a post-COVID-19 patient with shortness of breath on exertion and underlying cardiac issues, beyond using albuterol (bronchodilator)?
Are there concerns for impaired renal function when increasing the dose of Synthroid (levothyroxine) in patients with hypothyroidism and pre-existing kidney disease?
What are the diagnostic criteria and management strategies for secondary capillary leak syndrome in a middle-aged or older adult with a history of chronic illness, such as cancer or rheumatoid arthritis, presenting with symptoms like edema, hypotension, and hemoconcentration?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.